A Pilot, 15-month, randomised effectiveness trial of Risperidone long-acting injection (RLAI) versus oral atypical antipsychotic agents (AAP) in persons with bipolar disorder

✍ Scribed by K. N. Roy Chengappa; Scott R. Turkin; Patricia J. Schlicht; Sherry L. Murphy; Jaspreet S. Brar; Andrea Fagiolini; Patricia R. Houck; Ronald G. Garbutt; Noreen Fredrick

• Book ID: 111274124
• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: Dutch
• Weight: 612 KB
• Volume: 22
• Category: Article
• ISSN: 0924-2708
• DOI: 10.1111/j.1601-5215.2010.00458.x